Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Brexit creeping closer – or?

In this column, lawyer Pernilla Norman, tries to sort out the different Brexit options.

Anna Törner: To kill your darlings

Hopes were high when Anna Törner and her colleague started a study on a dietary supplement that seemed unbelievably good. “Enthusiastically, we dreamed of excit...

This is how Anette Steenberg will put Medicon Valley on the world map

Anette Steenberg has been CEO of the Swedish-Danish life science cluster Medicon Valley Alliance since 1 November last year. Life Science Sweden called her to a...

From spin-off to phase II

”The people there will basically become your new colleagues” – Carina Schmidt, former CEO of Athera, about working with different contractors.

Drug development creates new challenges for regulators

The stomach medication that became the biggest blockbuster of the 1990s

The omeprazole molecule was synthesised as early as 1979, but it took many years before the then Astra had an approved pharmaceutical. Once this happened, a tab...

They’re all doing it – buying drug research

December 12 the time has come for this year's annual partnering meeting Pharma Outsourcing in Stockholm. In Sweden this is a growing business, with Recipharm as...

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Saving lives worldwide with low-cost molecular diagnostics

High throughput testing for many upper respiratory tract pathogens thanks to automation technology

The perfect formula for decision-making

No one has the luxury not to take a decision, writes Helena Strigård at Swedenbio.

Globalt uttalande

Pfizers globala uttalande efter patentgodkännande av Prevenar 13 i Indien.

Delivering drugs with small devices

There are many challenges to overcome when delivering a drug orally. Getting the drug to survive the low pH of the ventricle and being released at the correct s...

Hoppfull studie om vaccin mot enterovirus och diabetes

Forskare vid bland annat Karolinska institutet har i studier på möss tagit fram ett vaccin mot virusinfektion som tros kan leda till diabetes typ 1.

When carelessness, forgetfulness and coincidence become the researcher’s best friend

Forgetfulness, coincidence and a stroke of luck hardly make up a fruitful method of serious research. Or do they? Actually, a number of important medical advanc...

Coordination of world-class research facilities

Four unique world-class research facilities are located just a few hours apart. Properly utilised, a Nordic centre for world-leading life science innovation and...

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

Swedish Healthtech Company 1928 Pushing Forward

The full service analytics platform is expanding the business.

A world-class research village

Eight years ago, Medicon Village was set up in Lund. Since then, this hub for research, innovation and business has developed enormously, and today the life sci...

It´s time to establish relations

Communication with the patient is the key to future healthcare, writes Hanna Brodda, editor in chief of Life Science Sweden.

Läkemedelsbolag ratar Trump

Flera tunga ledare har lämnat Donald Trumps industriråd i protest mot presidentens svaga agerande i samband med kravallerna i amerikanska Charlottesville. Tydli...

Hitflyttade ska sälja Sverige

Internationella nyckelpersoner hyllar Sverige som life science-nation i slutfasen av EMA-striden.

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...